SCHEMBL14513367

SCHEMBL14513367

CC(=O)c1ccccc1Oc1ncc(N)cc1NS(=O)(=O)c1ccc(Cl)s1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 5/20 0.55
MEN1 O00255 7/20 0.52
KMT2A Q03164 7/20 0.52
MAPT P10636 5/20 0.52
LMNA P02545 4/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
HTT P42858 4/20 0.52
RECQL P46063 3/20 0.52
POLB P06746 2/20 0.52
ALDH1A1 P00352 1/20 0.52
PIK3CA P42336 3/20 0.48
MTOR P42345 1/20 0.48
CCR4 P51679 3/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
CCR5 P51681 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
PTGES2 Q9H7Z7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904843 0.82 CCR2 (0.73) CCR2MEN1KMT2AMAPTLMNA
SCHEMBL4912717 0.82 CCR2 (0.61) CCR2MEN1KMT2AMAPTLMNA
SCHEMBL4904763 0.76 CCR2 (0.67) CCR2MEN1KMT2APIK3CAMTOR
SCHEMBL14006343 0.70 CCR2 (0.55) CCR2MEN1KMT2AMAPTLMNA
SCHEMBL4913044 0.70 CCR2 (0.69) CCR2CCR4CYP3A4CYP2C9CYP2C19
SCHEMBL4907421 0.70 CCR2 (0.57) CCR2MEN1KMT2AMAPTLMNA
SCHEMBL4935740 0.69 CCR2 (0.67) CCR2MEN1KMT2AMAPTLMNA
SCHEMBL4913288 0.69 CCR2 (0.69) CCR2MEN1KMT2AMAPTLMNA
SCHEMBL4909963 0.69 CCR2 (0.58) CCR2MEN1KMT2ALMNACCR4
SCHEMBL4907638 0.69 CCR2 (0.66) CCR2MEN1KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007067875-A2 PYRIDINYL SULFONAMIDE MODULATORS OF CHEMOKINE RECEPTORS GLAXO GROUP LIMTED (GB) 2007-06-14 WO disclosed